BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 13, 2000
View Archived Issues
AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder
Read More
Bristol-Myers Squibb and ICAgen to continue collaboration for atrial fibrillation
Read More
Buccal formulation of insulin will be developed by Lilly and Generex
Read More
Lupus therapy candidate granted orphan drug designation
Read More
BASF grants exclusive licenses for oncolytic compounds to Ilex
Read More
Low-dose nifekalant safely suppresses ventricular arrhythmias following AMI
Read More
Full, selective 5-HT1A antagonist characterized as having potential in depression, smoking cessation
Read More
SDZ-RAD continues to shine as a potential agent for transplantation
Read More
FR-167653 exerts beneficial effects in rat model of ischemia/reperfusion liver injury
Read More
NO donor FK-409 protects against ischemia/reperfusion injury of small intestine
Read More
HGS advances clinical development of novel protein
Read More
Antihypertensive activity demonstrated for new vasopressin receptor antagonists in rats
Read More
SRI presents novel steroid mimics useful for breast cancer
Read More
Pyrazoles as selective CB2 receptor modulators patented by SmithKline Beecham
Read More
Gaucher's disease treatment shows continued efficacy after 18 months
Read More
Synthesis and activity of novel PTK inhibitors reported by U.S. university researchers
Read More
Long-term, once-a-day efficacy demonstrated by HAART regimen including Coviracil
Read More
Canadian lab designs 5-ht6 receptor antagonists for schizophrenia
Read More
Crohn's disease therapy effective and safe in phase II trial
Read More
New antibiotics emerging from Pfizer R&D
Read More
Priority review granted to Femara as first-line breast cancer therapy
Read More
Several series of inhibitors of VLA-4-mediated cell adhesion from Elan covered by patents
Read More
Phase I clinical trials of Xcytrin begin for treatment of NSCLC and glioblastoma multiforme
Read More
C5 inhibitor receives fast track status for use in cardiopulmonary bypass
Read More
NCI sponsors additional phase II studies of Prostvac VF vaccine
Read More
DNA vaccine encoding C3d enhances immune response to influenza
Read More
Researchers uncover protein key to the development of Alzheimer's
Read More
Metformin completely reverses fatty liver in mouse model
Read More